Skip to content

Addiction: all studies

Page 648 of 860: studies 6,471 to 6,480 of 8,594, newest first. Back to the addiction overview

Research

Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.

European Neuropsychopharmacology February 2016 Alexandre Seillier, Andrea Giuffrida

Previous studies have shown that social withdrawal in the phencyclidine (PCP) rat model of schizophrenia results from deficient endocannabinoid-induced activation of CB1 receptors. To understand the underlying cognitive mechanisms of the social deficit in PCP-treated rats, we examined the impact of pharmacological manipulation of the endocannabinoid system on sociability (i.e. social approach)...

DOI: 10.1016/j.euroneuro.2015.12.009 (opens in new tab) Full text (opens in new tab) Endocannabinoid Odor discrimination Phencyclidine Social cognition

Large-Scale Functional Brain Network Reorganization During Taoist Meditation.

Brain Connectivity February 1, 2016 Tun Jao, Chia-Wei Li, Petra E Vértes et al.

Meditation induces a distinct and reversible mental state that provides insights into brain correlates of consciousness. We explored brain network changes related to meditation by graph theoretical analysis of resting-state functional magnetic resonance imaging data. Eighteen Taoist meditators with varying levels of expertise were scanned using a within-subjects counterbalanced design during...

Potential benefit of lamotrigine in managing ketamine use disorder.

Medical Hypotheses February 1, 2016 Ming-Chyi Huang, Lian-Yu Chen, Chih-Ken Chen et al.

Ketamine is an anesthetic derivative of phencyclidine (PCP; 'Angel dust') with dissociative, analgesic and psychedelic properties. Ketamine has become a popular recreational drug of abuse in many parts of the world in recent years. The preclinical studies demonstrate the reinforcing effects of ketamine and long-term ketamine abuse induces a delayed and persistent upregulation of dopamine...

Cannabis and Psychosis: a Critical Overview of the Relationship.

Current Psychiatry Reports February 1, 2016 Charles Ksir, Carl L. Hart

Interest in the relationship between cannabis use and psychosis has increased dramatically in recent years, in part because of concerns related to the growing availability of cannabis and potential risks to health and human functioning. There now exists a plethora of scientific articles addressing this issue, but few provide a clear verdict about the causal nature of the cannabis-psychosis...

The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors.

Neuropharmacology February 1, 2016 Maurizio S Riga, Analia Bortolozzi, Letizia Campa et al. 33 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a natural hallucinogen, acting as a non-selective serotonin 5-HT(1A)/5-HT(2A)-R agonist. Psychotomimetic agents such as the non-competitive NMDA-R antagonist phencyclidine and serotonergic hallucinogens (DOI and 5-MeO-DMT) disrupt cortical synchrony in the low frequency range (<4 Hz) in rat prefrontal cortex (PFC), an effect reversed by...

DOI: 10.1016/j.neuropharm.2015.10.016 (opens in new tab) Full text (opens in new tab) 5-HT Receptors Oscillatory activity Prefrontal cortex Sensorial cortical areas +10

A Case of Butane Hash Oil (Marijuana Wax)–Induced Psychosis

Substance Abuse January 28, 2016 Corey J. Keller, Evan C. Chen, Kimberly L. Brodsky et al. 27 citations

BACKGROUND: Marijuana is one of the most widely used controlled substances in the United States. Despite extensive research on smoked marijuana, little is known regarding the potential psychotropic effects of marijuana "wax," a high-potency form of marijuana that is gaining in popularity. CASE: The authors present a case of "Mr. B," a 34-year-old veteran who presented with profound psychosis in...

Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience

European Neuropsychopharmacology January 22, 2016 Thomas Pokorny, Katrin H. Preller, Rainer Kraehenmann et al. 148 citations

The mixed serotonin (5-HT) 1A/2A/2B/2C/6/7 receptor agonist psilocybin dose-dependently induces an altered state of consciousness (ASC) that is characterized by changes in sensory perception, mood, thought, and the sense of self. The psychological effects of psilocybin are primarily mediated by 5-HT2A receptor activation. However, accumulating evidence suggests that 5-HT1A or an interaction...

DOI: 10.1016/j.euroneuro.2016.01.005 (opens in new tab) Psilocybin Buspirone Hallucinogen 5-ht1 receptor +5

Human brain networks function in connectome-specific harmonic waves

Nature Communications January 21, 2016 Selen Atasoy, I. Donnelly, Joel Pearson

A key characteristic of human brain activity is coherent, spatially distributed oscillations forming behaviour-dependent brain networks. However, a fundamental principle underlying these networks remains unknown. Here we report that functional networks of the human brain are predicted by harmonic patterns, ubiquitous throughout nature, steered by the anatomy of the human cerebral cortex, the...

Oxytocin receptor gene variation predicts subjective responses to MDMA

Social Neuroscience January 20, 2016 Anya K. Bershad, Jessica Weafer, Matthew G. Kirkpatrick et al. 35 citations

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") enhances desire to socialize and feelings of empathy, which are thought to be related to increased oxytocin levels. Thus, variation in the oxytocin receptor gene (OXTR) may influence responses to the drug. Here, we examined the influence of a single OXTR nucleotide polymorphism (SNP) on responses to MDMA in humans. Based on findings that...

DOI: 10.1080/17470919.2016.1143026 (opens in new tab) MDMA Ecstasy Oxytocin receptor Single-nucleotide polymorphism +2

Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications

BMC Medical Ethics January 14, 2016 Melvyn W B Zhang, Keith M. Harris, Roger Ho 69 citations

BACKGROUND: Depressive disorders are a common form of psychiatric illness and cause significant disability. Regulation authorities, the medical profession and the public require high safety standards for antidepressants to protect vulnerable psychiatric patients. Ketamine is a dissociative anaesthetic and a derivative of a hallucinogen (phencyclidine). Its abuse is a major worldwide public...